Skip to main content
lexblog.com/lib/3APPW36Yviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Samsung Bioepsis, Biogen, and Fujifilm Invalidate Humira® Patents in UK",
    "url": "https://www.lexblog.com/2017/03/09/samsung-bioepsis-biogen-fujifilm-invalidate-humira-patents-uk/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-3APPW36Y",
        "url": "https://www.lexblog.com/lib/3APPW36Y/"
    },
    "datePublished": "2017-03-09T21:21:57-05:00",
    "dateModified": "2021-11-10T10:03:47-05:00",
    "author": {
        "@type": "Person",
        "name": "Nicole Gifford"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Intellectual Property",
    "sourceUrl": "http://www.biosimilarsip.com/?p=3622",
    "sourceStability": "may-move"
}